These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29512864)

  • 41. Treatment of Langerhans cell histiocytosis in children with etoposide.
    Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
    Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.
    Su M; Gao YJ; Pan C; Chen J; Tang JY
    Pediatr Hematol Oncol; 2018; 35(7-8):385-392. PubMed ID: 30693828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
    Wu FF; Gao YJ; Pan C; Chen J; Tang JY
    Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine.
    von Stebut E; Schadmand-Fischer S; Bräuninger W; Kreft A; Doberauer C; Steinbrink K
    Arch Dermatol; 2008 May; 144(5):649-53. PubMed ID: 18490592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploration of treatment in childhood Langerhans cell histiocytosis based on inflammatory and malignant symptoms: a pilot study.
    Lin HL; Zheng QQ; Huang RL; Hu R; Liu XD; Wang JY
    Orphanet J Rare Dis; 2024 Apr; 19(1):174. PubMed ID: 38654381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin.
    McCowage GB; Frush DP; Kurtzberg J
    J Pediatr Hematol Oncol; 1996 May; 18(2):154-8. PubMed ID: 8846128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
    Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
    Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Langerhans' cell histiocytosis: experience from a single center.
    Bansal D; Marwaha RK; Trehan A; Gupta V; Varma N
    Indian Pediatr; 2008 Aug; 45(8):685-8. PubMed ID: 18723913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
    Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
    Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood.
    Aricò M; Astigarraga I; Braier J; Donadieu J; Gadner H; Glogova E; Grois N; Henter JI; Janka G; McClain KL; Ladisch S; Pötschger U; Rosso D; Thiem E; Weitzman S; Windebank K; Minkov M;
    Br J Haematol; 2015 Apr; 169(2):241-8. PubMed ID: 25522229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study.
    Ng Wing Tin S; Martin-Duverneuil N; Idbaih A; Garel C; Ribeiro M; Parker JL; Defachelles AS; Lambilliotte A; Barkaoui M; Munzer M; Gardembas M; Sibilia J; Lutz P; Fior R; Polak M; Robert A; Aumaitre O; Plantaz D; Armari-Alla C; Genereau T; Berard PM; Talom GN; Pennaforte JL; Le Pointe HD; Barthez MA; Couillault G; Haroche J; Mokhtari K; Donadieu J; Hoang-Xuan K;
    Orphanet J Rare Dis; 2011 Dec; 6():83. PubMed ID: 22151964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
    Viana MB; Oliveira BM; Silva CM; Rios Leite VH
    Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric langerhans cell histiocytosis: single center experience over a 17-year period.
    İnce D; Demirağ B; Özek G; Erbay A; Ortaç R; Oymak Y; Kamer S; Yaman Y; Kundak S; Vergin C
    Turk J Pediatr; 2016; 58(4):349-355. PubMed ID: 28276205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis.
    Kudo K; Maeda M; Suzuki N; Kanegane H; Ohga S; Ishii E; Shioda Y; Imamura T; Imashuku S; Tsunematsu Y; Endo M; Shimada A; Koga Y; Hashii Y; Noguchi M; Inoue M; Tabuchi K; Morimoto A;
    Int J Hematol; 2020 Jan; 111(1):137-148. PubMed ID: 31758416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.
    Morimoto A; Shioda Y; Kudo K; Kanegane H; Imamura T; Koh K; Kosaka Y; Yuza Y; Nakazawa A; Saito AM; Watanabe T; Nakazawa Y
    Int J Hematol; 2023 Jul; 118(1):107-118. PubMed ID: 36871086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
    Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D
    Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.
    Barkaoui MA; Queheille E; Aladjidi N; Plat G; Jeziorski E; Moshous D; Lambilliotte A; Kebaili K; Pacquement H; Leverger G; Mansuy L; Entz-Werlé N; Bodet D; Schneider P; Pagnier A; Lutun A; Gillibert-Yvert M; Millot F; Toutain F; Reguerre Y; Thomas C; Tazi A; Emile JF; Donadieu J; Héritier S
    Br J Haematol; 2020 Dec; 191(5):825-834. PubMed ID: 32700439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center.
    Yağci B; Varan A; Cağlar M; Söylemezoğlu F; Sungur A; Orhan D; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    Pediatr Hematol Oncol; 2008 Jun; 25(5):399-408. PubMed ID: 18569842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
    Broadbent V; Pritchard J; Yeomans E
    Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.